Three products of New Horizon Health (HKG:6606) have recently been listed with the Hong Kong government's Department of Health under the Medical Device Administrative Control System (MDACS), a Tuesday bourse filing said.
The products include ColoClear, a screening test for colorectal cancer; Pupu Tube, a screening product to detect hemoglobin biomarkers associated with colorectal cancer; and UU Tube, a screening product for H. pylori.
Medical devices can be listed with the Department of Health using MDACS if they conform to the accepted standards of safety and performance.
Trading in the company's shares, which was suspended March 28, remains suspended.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。